ACUTE MYOCARDIAL INFARCTION (AMI)

This study is testing whether a new drug called ziltivekimab can help stabilize the fatty plaques in heart arteries after someone has a heart attack. About 332 participants who recently had a heart attack will be randomly assigned to receive either the new drug or a placebo injec…

This study is testing a new temporary heart pump device for patients experiencing cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood. The research aims to see if the device is safe and effective at stabilizing patients' blood pressure…

This study is testing if giving a powerful cholesterol-lowering drug (a PCSK9 inhibitor) very early in the hospital, right after a heart attack, can help prevent future heart problems. It will involve about 1,500 people who have had a heart attack and have multiple blocked arteri…

This study is testing whether a new, unapproved drug called ziltivekimab can help prevent future heart attacks, strokes, or death in people who have just had a heart attack. About 10,000 participants will give themselves a monthly injection of either the real drug or a placebo (d…

This study is testing a new, faster blood test for heart attacks that can be used right in primary care clinics. The goal is to help doctors quickly figure out if a patient's chest pain is a serious heart problem or something else. If successful, this could mean fewer unnecessary…

This study is testing a new AI-powered computer program called Willem™. The goal is to see if it can read heart monitor (ECG) tracings to spot a heart attack as well as, or better than, a human doctor. Researchers will compare the AI's accuracy and speed to standard doctor interp…

This study is testing whether heart attack patients can safely go home about one day after treatment instead of staying two or more days. Researchers want to see if the shorter hospital stay leads to similar recovery outcomes compared to standard care. The trial involves over 2,0…

This study is creating a detailed registry of 6,000 heart attack patients who received emergency artery-opening surgery at Zhongshan Hospital. Researchers will track patients for up to two years after their procedure to understand what complications occur and how well patients re…